INTRODUCTION
Adenomatous colon polyps are the cause of most colorectal cancers. At highest risk are adenomatous polyps (adenomas) with high-grade dysplasia [1] . A variety of techniques are used for colonoscopic polyp removal depending on polyp size and form, including mucosal or submucosal resection for larger sessile polyps [2] . Segmental resection may be required in more di cult cases.
Whole plant extract of Viscum album L. (Santalaceae; European mistletoe) is widely used as a complementary cancer
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ABSTRACT
Background & Aim: Extracts of Viscum album (European mistletoe) have immune-stimulatory and cytotoxic e ects, with trials showing a well-established e ect on the quality of life and prolonged survival in patients with advanced pancreatic cancer. Regression of tumours following intratumoural injection with Viscum album extract has been documented in individual cases. However, its in uence on colon polyps has not been investigated. Case presentation: We present the case of a 78-year-old Caucasian male who had undergone hemi-colectomy for a stage IIIC colon cancer but who refused adjuvant chemotherapy. Five years later a newly detected highgrade dysplasia colon adenoma was discovered; however, the adenoma could not be resected endoscopically and the patient did not consent to surgery. Intratumoural injections with Viscum album L extract (Quercus; Iscador®Qu) were administered twice in an attempt to limit tumour growth. Eight months a er the second intratumoural injection the adenoma had disappeared and biopsy revealed no intraepithelial dysplasia or adenoma. Conclusions: is is the rst report showing complete regression of a colon adenoma a er intratumoural injection with Viscum album extract. Prospective studies should evaluate if the treatment e ect is reproducible and if this approach could be a useful pre-operative measure for colon adenomas too large for endoscopic resection.
Key words: colon polyp -colorectal adenoma -Viscum album -European mistletoe -tumour regression. [3, 4] . A recent randomized controlled tiral (RCT) showed survival bene t in advanced pancreatic cancer [5] . Case reports have documented durable tumour regression [6] [7] [8] . In colorectal cancer, studies have shown bene ts in terms of reduced cancer recurrence, survival in advanced cancer, and perioperative suppression of natural killer cells [9] [10] [11] , but the speci c e ect of Viscum album extract on colon polyps has not been investigated. Viscum album extracts and several of its compounds are cytotoxic. Lectins from the extract, in particular, have strong apoptosis-inducing and immune stimulatory e ects. ese include in vivo and in vitro activation of monocytes/macrophages, granulocytes, natural killer cells, T-cells and dendritic cells, the induction of a variety of cytokines, and e ects on tumoural angiogenesis [12] [13] [14] .
Iscador®Qu (Weleda AG, Schwäbisch Gmünd, Germany) is an aqueous, lectin-rich extract of Viscum album L. grown on oak trees (Quercus) and is o en used in the treatment of J Gastrointestin Liver Dis, December 2014 Vol. 23 No 4: 449-452 colon cancer. Production involves fermenting the fresh plant with Lactobacilli spp and sterile ltration. Series 0 and 1 are packs of 7 1mL ampoules, typically given as subcutaneous injections 2 or 3 times weekly with ascending strength. Series 0 includes strengths 0.01mg/mL, 0.1mg/mL, and 1mg/mL. Series 1 includes strengths 0.1mg/mL, 1mg/mL, and 10mg/ mL ampoules. "Iscador®Qu 5mg spezial" is a 5mg presentation with a lectin content of 391± 18.3 ng/mL [15] . Iscador®Qu is licensed for the German market by the German Federal Institute for Drugs and Medical Devices.We report the case of a male patient who refused resection of a colon adenoma and received intratumoural injections with Viscum album extract.
CASE REPORT
A Caucasian man had undergone hemi-colectomy at age of 78 years for an adenocarcinoma of the le colon. He had been otherwise healthy with normal weight, and had never smoked. He drank 1-2 glasses of wine a few evenings a week and ate a balanced diet with meat no more than twice per week. His father had died of colon cancer at age 86.
e carcinoma had in ltrated the surrounding fat tissue, had caused carcinomatous lymphangitis, and had metastasized to 21 regional lymph nodes (17 adjacent to the colon, 4 along blood vessels). It was classi ed as adenocarcinoma pT3 pN2 cM0 pL1 V0 R0 G3, stage IIIC. e patient's carcinoembryonic antigen (CEA) level was within normal limits (< 3 ng/mL). The patient refused adjuvant chemotherapy but accepted complementary treatment with Viscum album extract (Iscador®Qu). He injected Iscador®Qu subcutaneously every two days at home, beginning with one pack of Series 0, then with Series 1 in treatment cycles of 4 weeks with treatment breaks of increasing length (2, 4, 6 weeks, then 3 months). He observed no reactions to the injections other than mild redness at the injection site initially a er each injection (later only at strength 10mg/mL). He also started taking a herbal remedy containing wild strawberry leaves and grape leaves (Hepatodoron®, Weleda AG, Schäbisch Gmünd, Germany), two tablets three times daily (ongoing when we last met this patient on 7th July 2014).
Colonoscopy and laboratory tests (including complete blood count, liver function tests, and CEA) were done at months 6, 12, and 24 postoperatively and were normal except for mild macrocytic anaemia. At 24 months, two small hyperplastic rectum polyps were detected and removed. He remained in good health except for a dental abscess at month 22, and had normal bowel movements without blood.
Five years postoperatively, now aged 83 years, this patient complained of psychological stress over several months due to the worsening health of his wife. Iscador® treatment breaks were therefore shortened to 4 weeks each. At routine colonoscopy that same month (Fig. 1) , three budding sessile polyps were discovered on biopsy from the distal and mid-sigmoid colon as well as the transverse colon ( Fig. 2A) . Pathology of the mid-sigmoid polyp revealed a broad-based tubular adenoma with high-grade intraepithelial dysplasia; the pathology was performed by a private pathologist (Nurtingen, Germany). e patient cancelled the planned endoscopic resection due to the hospitalization of his wife; she died only days later. One month later he accepted a renewed colonoscopy but did not consent to resection, fearing complications. Instead, "Iscador®Qu 5mg spezial" was injected directly into the polyp.
Eight months later the patient nally agreed to colonoscopic resection. An MRI of the abdomen revealed no colon wall transgressing tumour growth, no lymph node metastases, and no focal lesions. Chest X-ray showed mild, age-related emphysema. On colonoscopy the polyp had an uneven surface and had grown, measuring now 7x4 mm and 3mm in height (Fig. 2B) . Submucosal saline injection to raise the polyp revealed a non-li ing sign, indicating deeper submucosal in ltration so that endoscopic resection was not considered a viable option. 10mg Iscador®Qu was injected into the polyp and the area marked with methylene blue for later resection. No further biopsy was taken. Both intratumoural Viscum album injections were well tolerated.
Segmental colon resection was recommended but the patient decided against the intervention, fearing surgery could jeopardize his good general health. Nine months later, the methylene blue marked area was easily identi ed during colonoscopy but the polyp had now disappeared (Fig. 2C) . Biopsy samples taken from the area revealed no signs of intraepithelial dysplasia or adenoma. Patient perspective: "I believe the new tumour was a result of the stress from the illness of my wife. I decided against an operation because I did not want to risk my good health at the time. e good outcome con rmed to me that we should not blindly handover responsibility to doctors but also trust our own intuition. " e patient read the nal report and gave signed informed consent for its publication. is case is reported according to CARE guidelines [16] .
DISCUSSION
Following two intratumoural injections of Viscum album extract a complete regression of a high-grade adenomatous colon polyp was observed and confirmed by pathology.
e sequence of events we have documented in this patient -culminating in the disappearance of adenoma a er two intratumoural injections -indicate an e ect of Viscum album extract treatment. Spontaneous disappearance of colon polyps sometimes occurs in patients with familial adenomatous polyposis, and spontaneous remission of an invasive colorectal cancer has previously been reported [17, 18] . However, disappearance of colon polyps is otherwise uncommon [19] . Remission of malignant tumours a er intratumoural injection of Viscum album extracts has been reported for cutaneous B-cell lymphoma, cutaneous squamous cell carcinoma, and malignant melanoma [6] [7] [8] , but not yet for colon adenomas. e e ect is plausible given the known immune-stimulatory and cytotoxic e ects of Viscum album extract [12] [13] [14] .
e overall outcome in this patient, in light of his refusal of chemotherapy, was favourable: observed 5-year survival for stage IIIC colorectal cancer is only around 28% in these patients [20] . e subcutaneous Viscum album extract injections may have contributed to this outcome [9] but were not su cient to prevent adenoma formation. Case reports of tumour remission a er intratumoural injection suggest that concentration of the extract at the tumour site is of key importance.
Regardless of the fortunate outcome in this case, resection of colon adenoma is always advisable. Endoscopic resection can be done even for larger polyps, and the positive predictive value of a non-li ing sign for sub-mucosal invasion is only 80% [2, 21] . Other experienced practitioners may have attempted endoscopic resection in this patient.
A method to reduce polyp size could be useful in cases where an adenoma is too large for endoscopic resection and/ or when the patient, a er being fully informed of treatment options, does not accept the recommended therapy [22] .
The safety of Viscum album extracts has been well documented [13] . As part of the intended immune reaction, patients typically experience some redness and swelling at the subcutaneous injection site (as in this patient) and/or low-grade fever. Anaphylactic reactions are possible, but very rare [13] .
CONCLUSIONS
is is the rst report showing complete regression of a colon adenoma a er intratumoural injection with Viscum 
